Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.
Retroviruses and opportunistic infections - ninth conference. New antiviral agents. 24-28 February, Seattle, WA, USA.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.